Regulable vascular endothelial growth factor165 overexpression by ex vivo expanded keratinocyte cultures promotes matrix formation, angiogenesis, and healing in porcine full-thickness wounds

Tissue Engineering - Part A.

Volumn 14, Issue 1, 2008, Pages 19-27

  Dickens, Stijn ^a   Vermeulen, Pieter ^a   Hendrickx, Benoit ^a   Van Den Berge, Stefaan ^a   Vranckx, Jan J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; GROWTH KINETICS; PROTEINS; TISSUE; ACTIVATION ENERGY; CELLS; GENE TRANSFER; LIPOSOMES;

ANGIOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOSTAINING; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

CELL CULTURE; PROTEINS;

EOSIN; FIBRONECTIN; HEMATOXYLIN; LECTIN; LIPOSOME; TETRACYCLINE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN 165; ANTIINFECTIVE AGENT; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOPSY; CELL CULTURE; CELL SUSPENSION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIZATION; EX VIVO GENE TRANSFER; FEMALE; GENE SWITCHING; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; LECTIN BINDING SITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TISSUE REPAIR; UPREGULATION; WOUND FLUID; WOUND HEALING; ANIMAL CELL; ANIMAL TISSUE; CELL EXPANSION; EX VIVO STUDY; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; ANIMAL; AUTOTRANSPLANTATION; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; GENETICS; INJURY; METABOLISM; PATHOLOGY; TRANSPLANTATION;

SUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FIBRONECTINS; GENE EXPRESSION; KERATINOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; TETRACYCLINE; TRANSFECTION; TRANSPLANTATION, AUTOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING; WOUNDS AND INJURIES;

EID: 38349091360     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.a.2007.0060     Document Type: Article

References (49)

1. Singer A, Clark RA Mechanisms of disease, cutaneous wound healing. N. Engl. J. Med. 341, 738, 1999.
2. Brown GL, Nanney LB. Enhancement of wound healing by topical treatment with epidermal growth factor. N. Engl. J. Med. 321, 76, 1989.
3. Fu X, Li X, Cheng B, Chen W, Sheng Z. Engineered growth factors and cutaneous wound healing, success and possible questions in the past ten years. Wound Rep. Reg. 13, 122, 2005.
4. Metcalfe A,Ferguson M. Harnessing wound healing and regeneration for tissue engineering. Biochem. Soc. Trans. 33, 413, 2005.
5. Vranckx JJ, Slama J, Preuss S, Svensjöt, Visovatti S, Breuing K, Bartlett R, Pribaz J, Eriksson E. Wet wound healing. Plast Reconstr Surg 110, 1680, 2002.
6. Vranckx JJ, Yao F, Petrie N, Augustinova H, Hoeller D, Visovatti S, Slama J, Eriksson E. In vivo gene delivery of Ad-VEGF121 to full-thickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing. Wound Repair Regen. 13, 51, 2005.
7. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin. Oncol. 29(6 Suppl 16), 10, 2002.
8. Ribeiro LA, Bacci ML, Seren E, Tamanini C, Forni M. Characterization and differential expression of vascular endothelial growth factor isoforms and receptors in swine corpus luteum throughout estrous cycle. Mol. Reprod. Dev. 74, 163, 2006.
9. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc. Res. 65, 550, 2005.
10. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J. Cell. Mol. Med. 9, 777, 2005.
11. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375, 1992.
12. Gallico GG, O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N. Engl. J. Med. 311, 448, 1984.
13. Myers S, Navsaria H, Sanders R, Green C, Leigh I. Transplantation of keratinocytes in the treatment of wounds. Am. J. Surg. 170, 75, 1995.
14. Vogt PM, Thompson S, Andree C, Liu P., Breuing K, Hatzis D, Brown H, Mulligan RC, Eriksson E. Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc. Natl. Acad. Sci. U. S. A. 91, 9307, 1994.
15. Ferrara N, Gerber HP, LEcouter J. The biology of VEGF and its receptors. Nat. Med. 9, 669, 2003.
16. Bates DO, Jones RO. The role of vascular endothelial growth factor in wound healing. Int. J. Low. Extrem. Wounds 2, 107, 2003.
17. Bootle-Wilbraham CA, Tazzyman S, Thompson WD, Stirk CM, Lewis CE. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 4, 269, 2001.
18. Postle K, Nguyen TT, Bertrand KP. Nucleotide sequence of the repressor gene of the tn10 tetracycline resistance determinant. Nuc. Acids Res. 12, 4849, 1984.
19. Hillen W, Berens C. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48, 345, 1994.
20. Yao F, Svensjö T, Winkler T, Lu Z, Eriksson C, Eriksson E. Tetracycline repressor, TetR, rather than the TetR-mammalian cell transcription factor fusion derivatives, regulated inducible gene expression in mammalian cells. Hum. Gene Ther. 9, 1939, 1998.
21. Caligiuri G, Rossignol P, Julia P, Groyer E, Mouradian D, Urbain D, Misra N, Ollivier V, Sapoval M, Boutouyrie P, Kaveri SV, Nicoletti A, Lafont A. Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 26, 618, 2006.
22. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, Bouloumie A. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53, 1285, 2004.
23. Barreca A, De Luca M, Del Monte P, Bondanza S, Damonte G, Cariola G, Di Marco E, Giordano G, Cancedda R, Minuto F. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J. Cell. Physiol. 151, 262, 1992.
24. Vranckx JJ, Yao F, Eriksson E. Gene transfer of growth factors for wound repair. In: D. Rovee, H. Maibach, Eds. The Epidermis in Wound Healing. Boca Raton, FL: CRC Press, 2004, pp. 269-283.
25. Coral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblast growth factor during ischaemic wound healing. Arch. Surg. 134, 200, 1999.
26. Dvorak HF, Detmar M, Claffey KP, Nagy JA, Van De Water L, Senger DR. Vascular permeability factor/vascular endothelial factor: an important mediator of angiogenesis in malignacy and inflammation. Int. Arch. Allergy Immunol. 107, 233, 1995.
27. Howdieshell TR, Webb WL, Sathyanarayana, McNeil PL. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion. Surgery 133, 528, 2003.
28. Artuc M, Hermes B, Steckelings UM, Grutzkau A, Henz BM. Mast cells and their mediators in cutaneous wound healing - active participants or innocent? Exp. Dermatol. 8, 1, 1999.
29. Michenko A, Bauer T, Salceda S, Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Invest. 71, 374, 1999.
30. Deodato B, Arsic N, Zentilin L. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther. 9, 777, 2002.
31. Tsou R, Fathke C, Wilson L, Wallace K, Gibran N, Isik F. Retroviral delivery of dominant-negative vascular endothelial growth factor receptor type 2 to murine wounds inhibits wound angiogenesis. Wound Repair Regen. 10, 222, 2002.
32. Brown NJ, Smyth EA, Cross SS, Reed MW. Angiogenesis induction and regression in human surgical wounds. Wound Repair Regen. 10, 245 2002.
33. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J. Invest. Dermatol. Symp. Proc. 5, 40, 2000.
34. Isner J, Pieczek A, Shainfield R. Clinical evidence of angiogenesis after arterial gene transfer of hVEGF165 in patients with limb ischemia. Lancet 348, 370, 1996.
35. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 13, 7, 2005.
36. Rumalla VK.,Borah GL. Cytokines,growth factors and plastic surgery. Plastic. Reconstr. Surg. 108, 604, 2001.
37. Clark RAF. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol 94, 128S, 1990.
38. Mitsi M, Hong Z, Costello CE, Nugent MA. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry 45, 10319, 2006.
39. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164, 2003.
40. Relou IA, Damen CA, van der Schaft DW, Groenewegen G, Griffioen AW. Effect of culture conditions on endothelial cell growth and responsiveness. Tissue Cell 30, 525, 1998.
41. Cai J, Jiang WG, Ahmed A, Boulton M. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2,SH-PTP1 and eNOS. Microvasc. Res. 71, 20, 2006.
42. Dardik R, Inbal A. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp. Cell Res. 312, 2973, 2006.
43. Duan HX, Cheng LM, Jian W, Hu LS, Lu GX. Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood. Cell Biol. Int. 30(12), 1018, 2006.
44. Collen A., Hanemaaijer R., Lupu F.,Quax PH.,van Lent N., Grimbergen J, Peters E, Koolwijk P, Van Hinsbergh VW. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood 101, 1810, 2003.
45. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9 and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 160, 673, 2002.
46. Krengel S, Alexander M, Brinckmann J, Tronnier M. MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light. J. Cutan. Pathol. 29, 390,2002.
47. Tjwa M, Luttun A, Auterio M, Carmeliet P. VEGF and PLGF: two pleiotropic growth factors with distinct roles in development and hemeostasis. Cell Tissue Res. 314, 5, 2003.
48. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP. VEGF and PLGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20, 1495, 2006.
49. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Natl. Acad. Sci. U. S. A. 89, 5547, 1992.